|
|
25-二羟维生素D3对2型糖尿病并发症作用机制的研究进展
|
Abstract:
2型糖尿病(T2DM)患病过程中会产生多种慢性并发症，严重降低患者生活质量，增加经济负担。因此，对于T2DM患者，除控制好血糖水平外，对于并发症的预防与治疗同样需引起重视，但由于其发生机制复杂、影响因素众多，诊疗方案还有待进一步优化。VD作为脂溶性激素参与人体内多种代谢过程，近年来逐渐成为研究热点，VD水平与T2DM慢性并发症存在一定相关性且其作用机制多样。本文总结分析了目前VD对于T2DM常见慢性并发症，包括大血管、微血管、周围神经病变、骨质疏松之间的影响及作用机制的研究进展，为T2DM慢性并发症的诊疗提供新思路。
Type 2 diabetes mellitus (T2DM) can lead to a variety of chronic complications during its course, which significantly reduces the quality of life for patients and increases the economic burden. Therefore, for T2DM patients, in addition to controlling blood sugar levels, the prevention and treatment of complications also need to be taken seriously. However, due to the complex mechanisms and numerous influencing factors, the diagnosis and treatment plans still need to be further optimized. Vitamin D (VD), as a fat-soluble hormone, participates in various metabolic processes in the human body and has gradually become a research hotspot in recent years. There is a certain correlation between VD levels and chronic complications of T2DM, and its mechanisms of action are diverse. This article, combined with relevant references, summarizes and analyzes the current research progress on the impact and mechanisms of VD on common chronic complications of T2DM, including macrovascular, microvascular, peripheral neuropathy, and osteoporosis, providing new ideas for the diagnosis and treatment of chronic complications of T2DM.
| [1] | 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版) [J]. 中国实用内科杂志, 2021, 41(8): 668-695. |
| [2] | 谢忠建, 程群, 丁悦. 维生素D代谢和作用[J]. 中华骨质疏松和骨矿盐疾病杂志, 2018, 11(1): 26-33. |
| [3] | 张菊梅. 血清25-羟维生素D水平与糖尿病患者胰岛素抵抗的相关性分析[J]. 大医生, 2024, 9(9): 108-110. |
| [4] | 邹静雯, 王宇茹, 王云, 等. 维生素D改善胰岛素抵抗的研究进展[J]. 中国药业, 2023, 32(3): 127-132. |
| [5] | 周晓春, 陈晓. 维生素D与2型糖尿病关系的研究进展[J]. 中国全科医学, 2014, 17(14): 1577-1580. |
| [6] | 王艳, 陈燕, 季黎明, 等. 不同血清25-羟维生素D水平的2型糖尿病患者颈动脉内膜中层厚度的变化[J]. 临床和实验医学杂志, 2016, 15(5): 445-447. |
| [7] | Grübler, M.R., März, W., Pilz, S., Grammer, T.B., Trummer, C., Müllner, C., et al. (2017) Vitamin-D Concentrations, Cardiovascular Risk and Events—A Review of Epidemiological Evidence. Reviews in Endocrine and Metabolic Disorders, 18, 259-272. https://doi.org/10.1007/s11154-017-9417-0 |
| [8] | 冯玲, 徐芳, 刘依然, 等. 血清25-羟维生素D_3与非肥胖2型糖尿病患者大血管病变的相关性研究[J]. 中国医刊, 2022, 57(5): 498-501. |
| [9] | 葛欣联. 血清25羟基维生素D_3及MCP-1水平与2型糖尿病及颈动脉粥样硬化的关系研究[D]: [硕士学位论文]. 石家庄: 河北医科大学, 2014. |
| [10] | Samsu, N. (2021) Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment. BioMed Research International, 2021, Article ID: 1497449. https://doi.org/10.1155/2021/1497449 |
| [11] | 曹清清, 葛欣联, 王绵, 等. 2型糖尿病肾病患者血清25羟维生素D_3变化及其与肾功能指标、炎性因子的相关性[J]. 疑难病杂志, 2015, 14(12): 1245-1248. |
| [12] | 朱小娟, 武俏颖, 兰姗, 等. 沉默1,25-二羟维生素D_3受体基因对高糖诱导的肾小管上皮细胞解偶联蛋白2表达及氧化应激的影响[J]. 中国中西医结合肾病杂志, 2017, 18(11): 987-990. |
| [13] | Tu, Q., Qin, J., Dong, H., Lu, F. and Guan, W. (2011) Effects of Panax notoginoside on the Expression of TGF-β1 and Smad-7 in Renal Tissues of Diabetic Rats. Journal of Huazhong University of Science and Technology (Medical Sciences), 31, 190-193. https://doi.org/10.1007/s11596-011-0250-5 |
| [14] | 李敏州, 高彦彬, 马鸣飞, 等. 糖尿病肾病发病机制研究进展[J]. 中国实验方剂学杂志, 2012, 18(22): 344-349. |
| [15] | 杜渊, 蒋宏伟, 李春庆, 等. 25羟维生素D与中国人群糖尿病肾病进展风险相关性的Meta分析[J]. 海南医学, 2021, 32(1): 119-127. |
| [16] | Trohatou, O., Tsilibary, E., Charonis, A., Iatrou, C. and Drossopoulou, G. (2017) Vitamin D3 Ameliorates Podocyte Injury through the Nephrin Signalling Pathway. Journal of Cellular and Molecular Medicine, 21, 2599-2609. https://doi.org/10.1111/jcmm.13180 |
| [17] | 贺诗雨, 吕祎, 兰凯. 活性维生素D对糖尿病肾病中肾保护作用的研究进展[J]. 中国中西医结合肾病杂志, 2022, 23(9): 839-841. |
| [18] | Szymczak-Pajor, I. and Śliwińska, A. (2019) Analysis of Association between Vitamin D Deficiency and Insulin Resistance. Nutrients, 11, Article No. 794. https://doi.org/10.3390/nu11040794 |
| [19] | 邹敏书, 余健, 聂国明, 等. 维生素D对高糖诱导足细胞胰岛素抵抗的保护作用[J]. 临床儿科杂志, 2014, 32(5): 471-475. |
| [20] | Contreras-Bolívar, V., García-Fontana, B., García-Fontana, C. and Muñoz-Torres, M. (2021) Mechanisms Involved in the Relationship between Vitamin D and Insulin Resistance: Impact on Clinical Practice. Nutrients, 13, Article No. 3491. https://doi.org/10.3390/nu13103491 |
| [21] | 张锦. 血清25-羟维生素D3、VEGF、整合素αvβ3、α9β1在2型糖尿病视网膜病变中的表达及意义[D]: [硕士学论文] 郑州: 郑州大学, 2020. |
| [22] | Zhang, J., Upala, S. and Sanguankeo, A. (2017) Relationship between Vitamin D Deficiency and Diabetic Retinopathy: A Meta-Analysis. Canadian Journal of Ophthalmology, 52, 219-224. https://doi.org/10.1016/j.jcjo.2016.10.004 |
| [23] | Lu, L., Lu, Q., Chen, W., Li, J., Li, C. and Zheng, Z. (2018) Vitamin D3 Protects against Diabetic Retinopathy by Inhibiting High-Glucose-Induced Activation of the ROS/TXNIP/NLRP3 Inflammasome Pathway. Journal of Diabetes Research, 2018, Article ID: 8193523. https://doi.org/10.1155/2018/8193523 |
| [24] | Lazzara, F., Longo, A.M., Giurdanella, G., Lupo, G., Platania, C.B.M., Rossi, S., et al. (2022) Vitamin D3 Preserves Blood Retinal Barrier Integrity in an in Vitro Model of Diabetic Retinopathy. Frontiers in Pharmacology, 13, Article ID: 971164. https://doi.org/10.3389/fphar.2022.971164 |
| [25] | Putz, Z., Martos, T., Németh, N., Körei, A.E., Vági, O.E., Kempler, M.S., et al. (2014) Is There an Association between Diabetic Neuropathy and Low Vitamin D Levels? Current Diabetes Reports, 14, Article No. 537. https://doi.org/10.1007/s11892-014-0537-6 |
| [26] | Karonova, T., Stepanova, A., Bystrova, A. and Jude, E.B. (2020) High-Dose Vitamin D Supplementation Improves Microcirculation and Reduces Inflammation in Diabetic Neuropathy Patients. Nutrients, 12, Article No. 2518. https://doi.org/10.3390/nu12092518 |
| [27] | 郭威, 石小霞, 刘丹, 等. 维生素D_2注射液联合硫辛酸注射液治疗2型糖尿病合并糖尿病周围神经病变患者的临床研究[J]. 中国临床药理学杂志, 2022, 38(19): 2263-2267. |
| [28] | 廖清睿, 朱钊, 吴敏. 维生素D干预糖尿病周围神经病变机制的研究进展[J]. 微循环学杂志, 2022, 32(4): 80-84. |
| [29] | 王林, 李春霖. 钙剂和维生素D在老年骨质疏松症中的应用[J]. 中国临床保健杂志, 2022, 25(1): 30-33. |
| [30] | 尹劲, 周兆文, 普有登, 等. 老年人群骨质疏松发生情况及血清25-羟维生素D对其影响[J]. 国际老年医学杂志, 2023, 44(1): 67-70. |
| [31] | 娄阳. 2型糖尿病患者视网膜病变与骨代谢生化标志物的相关性研究[D]: [硕士学位论文]. 济南: 山东大学, 2019. |
| [32] | 许桂平, 张尧, 马文杰, 等. 2型糖尿病患者血25-羟维生素D水平的改变及其对血糖与骨量的影响[J]. 中华临床医师杂志(电子版), 2013, 7(24): 11206-11210. |
| [33] | 郭耀, 霍建忠, 吴斗, 等. Chemerin信号通路在骨质疏松症中的作用[J]. 中国骨质疏松杂志, 2018, 24(12): 1671-1675+1680. |
